SCHEMBL18725504

SCHEMBL18725504

NC(=O)OC1CNC(=O)C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.36
PDE4A P27815 6/20 0.33
PDE4B Q07343 4/20 0.33
PDE4C Q08493 4/20 0.33
PDE4D Q08499 4/20 0.33
CYP3A4 P08684 2/20 0.30
VEGFA P15692 1/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
CYP1A2 P05177 1/20 0.30
MAPT P10636 1/20 0.30
CYP2C9 P11712 1/20 0.30
ALOX15 P16050 1/20 0.30
CREBBP Q92793 1/20 0.30
KDM4E B2RXH2 1/20 0.30
PDE5A O76074 1/20 0.30
TNF P01375 1/20 0.30
MAPK1 P28482 1/20 0.30
BLM P54132 1/20 0.30
PDE1A P54750 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28830395 1.00 ATM (0.36) ATMPDE4APDE4BPDE4CPDE4D
SCHEMBL27358272 0.82 PDE4A (0.33) PDE4APDE4BPDE4CPDE4D
SCHEMBL31441632 0.82 ITGB1 (0.32) PDE4APDE4BPDE4CPDE4D
SCHEMBL792893 0.82 ITGB1 (0.32) PDE4APDE4BPDE4CPDE4D
SCHEMBL22635868 0.81 ATM (0.34) ATMKMT2A
SCHEMBL21026696 0.80 POLB (0.34) PDE4APDE4BPDE4CPDE4DCYP3A4
SCHEMBL3744381 0.80 POLB (0.34) PDE4APDE4BPDE4CPDE4DCYP3A4
SCHEMBL18472040 0.80 POLB (0.34) PDE4APDE4BPDE4CPDE4DCYP3A4
SCHEMBL18725518 0.78 ATM (0.35) ATM
SCHEMBL18009175 0.78 KEAP1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118201916-A Piperazinylsulfonylaryl compounds for the treatment of bacterial infections 豪夫迈·罗氏有限公司 2024-06-14 CN disclosed
CN-116848116-A Novel compounds as dual androgen receptor and phosphodiesterase inhibitors 日东制药株式会社 2023-10-03 CN disclosed
WO-2023072794-A1 PIPERAZINYLSULFONYLARYL COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS F. HOFFMANN-LA ROCHE AG (CH) 2023-05-04 WO disclosed
CN-114845711-A Inhibitors of RAF kinase 金耐特生物制药公司 2022-08-02 CN disclosed
WO-2020224568-A1 CDK INHIBITORS QILU REGOR THERAPEUTICS INC. (CN) 2020-11-12 WO disclosed
EP-3307741-A1 POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC M2 RECEPTOR Bayer Pharma Aktiengesellschaft (DE) 2018-04-18 EP disclosed
EP-3154976-A2 PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA Merck Sharp & Dohme Corp. (US) 2017-04-19 EP disclosed